Cargando…

Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease

BACKGROUND: Interleukin-6 (IL-6) is implicated in the pathogenesis of coronary heart disease (CHD), and IL-6 expression has associated with reduced DNA methylation of its gene promoter. However, there are no data on IL-6 promoter methylation and the risk of CHD. OBJECTIVE: To examine whether IL-6 pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Hong-Peng, Guo, Ying-Yu, Che, Lin, Wu, Xian-Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074066/ https://www.ncbi.nlm.nih.gov/pubmed/27627640 http://dx.doi.org/10.5935/abc.20160124

Ejemplares similares

Relationship of hypomethylation CpG islands in interleukin-6 gene promoter with IL-6 mRNA levels in patients with coronary atherosclerosis
por: Mohammadpanah, Monireh, et al.
Publicado: (2020)

GCK Gene-Body Hypomethylation Is Associated with the Risk of Coronary Heart Disease
por: Xu, Limin, et al.
Publicado: (2014)

Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus
por: Tang, Chun, et al.
Publicado: (2014)

LINE-1 Hypomethylation is Associated with the Risk of Coronary Heart Disease in Chinese Population
por: Wei, Li, et al.
Publicado: (2014)

Quantifying the Importance of Interleukin-6 for Coronary Heart Disease
por: Neal, Bruce
Publicado: (2008)

Polymorphisms of −174G>C and −572G>C in the Interleukin 6 (IL-6) Gene and Coronary Heart Disease Risk: A Meta-Analysis of 27 Research Studies
por: Zheng, Guo-hua, et al.
Publicado: (2012)

Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease
por: Jin, Jialie, et al.
Publicado: (2023)

Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
por: Zhou, Qing-Bing, et al.
Publicado: (2020)

Distinct Functional Patterns of Gene Promoter Hypomethylation and Hypermethylation in Cancer Genomes
por: Shen, Xiaopei, et al.
Publicado: (2012)

Association between polymorphisms in interleukin-18 promoter and risk of coronary artery disease: a meta-analysis
por: Lian, Zheng, et al.
Publicado: (2019)

LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma
por: Zhang, Hui, et al.
Publicado: (2019)

An Association Study between Genetic Polymorphism in the Interleukin-6 Receptor Gene and Coronary Heart Disease
por: Zhou, Jiangqing, et al.
Publicado: (2014)

Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma
por: Gao, Xu-dong, et al.
Publicado: (2014)

Differentially hypomethylated cell-free DNA and coronary collateral circulation
por: Ahn, Jongseong, et al.
Publicado: (2022)

E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter
por: Liu, Kai-Long, et al.
Publicado: (2022)

Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells
por: Xie, Zhongyu, et al.
Publicado: (2018)

Analysis of the Role of Interleukin 6 Receptor Haplotypes in the Regulation of Circulating Levels of Inflammatory Biomarkers and Risk of Coronary Heart Disease
por: Gigante, Bruna, et al.
Publicado: (2015)

IL10 hypomethylation is associated with the risk of gastric cancer
por: Tang, Junjian, et al.
Publicado: (2021)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

ALV Integration-Associated Hypomethylation at the TERT Promoter Locus
por: Lam, Gary, et al.
Publicado: (2018)

miR194 hypomethylation regulates coronary artery disease pathogenesis
por: Duan, Lian, et al.
Publicado: (2022)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD
por: Drummer, Charles I. V., et al.
Publicado: (2021)

Association of Interleukin-6 Gene Promoter Polymorphism with Coronary Artery Disease in Pakistani Families
por: Satti, Humayoon Shafiq, et al.
Publicado: (2013)

Hypomethylation Causes MIR21 Overexpression in Tumors
por: Lu, Jun, et al.
Publicado: (2020)

Promoter Hypomethylation of TGFBR3 as a Risk Factor of Alzheimer’s Disease: An Integrated Epigenomic-Transcriptomic Analysis
por: Song, Hui, et al.
Publicado: (2022)

MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2015)

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer
por: Wu, Yinfang, et al.
Publicado: (2017)

Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer
por: Sung, Hye Youn, et al.
Publicado: (2017)

Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis
por: Ji, Jiang, et al.
Publicado: (2020)

Hypomethylation of MIR‐378 5’‐flanking region predicts poor survival in young patients with myelodysplastic syndrome
por: Wu, De‐hong, et al.
Publicado: (2019)

Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma
por: Du, Xiaoxiao, et al.
Publicado: (2019)

Hypomethylation of Rnase6 Promoter Enhances Proliferation and Migration of Murine Aortic Vascular Smooth Muscle Cells and Aggravates Atherosclerosis in Mice
por: Fang, YongPeng, et al.
Publicado: (2021)

Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease
por: Yang, Fangkun, et al.
Publicado: (2023)

Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
por: Upchurch, Garland Michael, et al.
Publicado: (2016)

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Publicado: (2012)

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Publicado: (2012)

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
por: Danesh, John, et al.
Publicado: (2008)

Interactions between vitamin D receptor (VDR) gene and Interleukin-6 gene and environment factors on coronary heart disease risk in a Chinese Han population
por: Jun, Ma, et al.
Publicado: (2017)

Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ti1gfibuni51hj7f6kq2era17